Skip to main content

Table 5 Concordance analysis of cardiac findings between FLT and FDG-PET in subjects satisfying the HRS criteria for CS (N = 12)

From: FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET

  Agreement
Subjects with LV uptake 0.81 (95% CI 0.47 to 1.0)
Subjects with RV uptake 0.57 (95% CI 0.08 to 1.0)
# of LV segments involved 0.81 (95% CI 0.49 to 0.94)
# of segments in LAD territory 0.81 (95% CI 0.51 to 0.94)
# of segments in LCX territory 0.54 (95% CI 0.03 to 0.83)
# of segments in RCA territory 0.84 (95% CI 0.56 to 0.95)
Maximum LV SUV 0.22 (95% CI − 0.38 to 0.69)
Maximum RV SUV 0.36 (95% CI − 0.24 to 0.76)
Mean segmental SUV  − 0.002 (95% CI − 0.58 to 0.57)
LV SUVTotal 0.20 (95% CI − 0.42 to 0.70)
  1. Agreement between categorical and continuous variables was assessed using Cohen’s kappa and the intraclass correlation coefficient, respectively